You are here

antisense

GSK licenses Ionis' midphase hepatitis B program for $25M

Fierce Biotech

Tue, 08/27/19 - 09:51 am

Ionis Pharmaceuticals

Biogen’s Experimental Drug Shows Promise for Genetic Form of ALS

BioSpace

Wed, 05/15/19 - 11:43 pm

Ionis Pharmaceuticals

Audentes to develop vectorized antisense therapies with Nationwide

BioCentury

Mon, 04/8/19 - 11:23 pm

Audentes Therapeutics

AstraZeneca and Ionis target diabetes with antisense approach to regenerating pancreatic cells

Fierce Biotech

Mon, 10/22/18 - 12:17 pm

Ionis Pharmaceuticals

type 2 diabetes

Roche gets option to Ionis' antisense dry AMD candidate

BioCentury

Wed, 10/10/18 - 10:51 pm

Ionis Pharmaceuticals

dry age-related macular degeneration

PureTech Receives Up To $36 Million from Roche to Develop Oral Delivery of Antisense Oligonucleotides

CP Wire

Fri, 07/20/18 - 11:29 am

drug development

Ionis-backed Dynacure bags €47M to start clinical trials

Fierce Biotech

Fri, 07/6/18 - 10:42 pm

Ionis Pharmaceuticals

oligonucleotide

CNM muscular disorders

AstraZeneca hauls kidney disease drug into the clinic after handing Ionis $30M in cash, $300M in milestones

Endpoints

Tue, 02/20/18 - 11:07 am

Ionis Pharmaceuticals

J&J goes back to Ionis for its second experimental pill for a GI autoimmune disease

Endpoints

Thu, 11/16/17 - 11:08 am

Ionis Pharmaceuticals

autoimmune disease

IONIS-JBI2-2.5Rx

Alzheimer’s: Ionis Initiates phase I/II trial for antisense drug

GoinPharma

Mon, 10/16/17 - 09:37 pm

Alzheimer's disease

Ionis Pharmaceuticals

Purdue Pharma Puts Skin In The Game With Psoriasis Deal

Seeking Alpha

Thu, 12/15/16 - 10:09 am

Interleukin Genetics Cites Role in Key Antisense Drug Trial Published in The Lancet

Cafepharma/Globe Newswire

Thu, 09/22/16 - 09:11 am

Interleukin Genetics

clinical trials

IONIS-APO(a)-LRX

Isis-AstraZeneca Collaboration For Antisense Drugs Gets HSR Clearance

NASDAQ.com

Sat, 09/12/15 - 01:21 pm

Isis Pharmaceuticals

Isis Pharmaceuticals: Another Regeneron (Or Even Better) In The Making?

Seeking Alpha

Sun, 06/14/15 - 10:48 pm

Isis Pharmaceuticals

Bayer fronting $155M for a promising anticoagulant from Isis Pharma

Fierce Biotech

Mon, 05/4/15 - 10:08 am

Isis Pharmaceuticals

Isis/AstraZeneca Expand Antisense Technology Collaboration

Yahoo/Zacks

Sat, 11/15/14 - 09:30 am

Isis Pharmaceuticals

hepatocellular carcinoma

prostate cancer

Isis shares jump on promising spinal disorder treatment data

Yahoo/Reuters

Fri, 02/21/14 - 05:01 pm

Isis Pharmaceuticals

Isis Earns $5 Million in Milestone Payment from GSK for Advancement of ISIS-GSK4 Rx

Yahoo

Fri, 11/15/13 - 11:34 am

Isis Pharmaceuticals

Isis Earns $7 Million in Milestone Payments from GSK for Advancement of ISIS-GSK3 Rx to Treat Viral Infection

Yahoo

Mon, 10/7/13 - 08:55 am

Isis Pharmaceuticals

viral infections

Further Win For Isis's Antisense Pipeline Adds To Buyout Rationale

Seeking Alpha

Tue, 09/3/13 - 09:42 am

Isis Pharmaceuticals

Pages